Adaptogenic Herbs Stress Formulas Test Every Ingredient Solo

The Oasis Health Journal · Submitted October 15, 2026 · 3:00 PM EDT

By June Mackerel · Edited by Colette Ward

The bottle on the shelf lists seven adaptogenic herbs, each with a rather impressive botanical name in italics and a milligram quantity beside it. The label speaks of synergy, of ingredients working in concert, of benefits that exceed what any single herb might offer. One reads it and pictures a well-rehearsed ensemble, something orchestral, something that has practiced together.

One then looks for the study that measured the ensemble's performance, and finds instead a series of solos, none of which appear to have been in the same room at the same time.

I have gone through the research, which is what one does when confronted with marketing language, and I am afraid the situation is precisely as disappointing as that metaphor suggests.

What Adaptogenic Herbs Actually Got Tested Together

In a six-month study of five hundred eight Saudi adults, researchers examined knowledge and use patterns of ashwagandha. Nearly half the participants demonstrated low knowledge levels, which one imagines made them ideal customers. Most learned about it from social media. Many used ashwagandha alongside other herbal supplements or dietary supplements, which raised concerns about supplement-supplement interactions and cumulative adverse effects.

The study observed that concurrent use was happening. It did not test whether the combinations were effective, or safe, or different in any measurable way from taking the herbs separately while standing in different rooms. One imagines the researchers were somewhat concerned about the interactions. They published the concern. They did not, apparently, follow it up with a trial.

Separately, which is rather the theme here, researchers gave female mice rhodiola rosea root powder during a nineteen-day chronic mild stress protocol. The rhodiola was standardized to three percent salidroside, which is the sort of detail one includes when one is being serious. The mice received rhodiola alone. At the end, the treated mice showed reduced anxiety-like behavior in two standard tests. They spent more time in the open arms of an elevated maze, which mice generally avoid unless they are feeling rather confident about things.

They also showed more locomotor activity and more time in the center of an open field. Serum corticosterone, a stress hormone, dropped significantly.

The effect was clear, the study was careful, and the rhodiola was entirely unaccompanied by ashwagandha, holy basil, schisandra, or any of the other adaptogen blend neighbors it shares a capsule with in retail products. It is not clear what one is meant to conclude from this about combinations, except perhaps that rhodiola works and mice are not purchasing blends.

The Asparagus That Worked Alone, Apparently

A review of asparagus saponins, with particular attention to shatavarin-IV from Asparagus racemosus, described the plant's adaptogenic, antioxidant, immunomodulatory and antiproliferative properties. Shatavarin-IV is regarded as the most important steroidal saponin responsible for most of the pharmacological effects. The review covered biosynthesis, mechanistic pathways, safety, marketed traditional products, and clinical trial aspects, all in considerable detail, all about the one plant, alone, without obvious assistance from rhodiola or holy basil or anything else one might find listed on a combination formula label.

I looked for the part where they added a second herb to see if things improved.

There was no such part.

Stress Relief Adaptogens and the Theory of Synergy

A review of stress relief adaptogens in long-lasting brain fatigue discussed how these compounds interact with the hypothalamus-pituitary axis and the sympathoadrenal system, which are both things one has and would prefer kept in good order. The paper proposed that adaptogens target multiple mediators within adaptive signaling pathways, involving neuronal, microglia, immunocompetent and endothelial cells. It noted that adaptogens comprise two major chemical groups: phenolic derivatives related to monoamine neurotransmitters, and tetracyclic and pentacyclic glycosides related to steroid hormones.

The review emphasized multitarget mechanisms, time-dependent dual responses, and dose-dependent hormetic effects.

The clinical trials cited in that review tested individual herbs. One after another, individually, the way one might audition sopranos without ever putting them on stage together. The theory of multitarget activity is compelling. The evidence that combining adaptogenic herbs for stress produces a different, better, or indeed measurable result compared to taking them sequentially in separate capsules does not appear to exist in human trials.

It may exist somewhere, perhaps in a file drawer, or on a conference poster no one read, or in the imagination of whoever wrote the label copy, but it is not in the published literature one can actually locate and cite without inventing things.

How to Choose Adaptogenic Supplements When the Combinations Are Untested

A review of Rhodiola rosea discussed its anti-inflammatory, antioxidant and immune regulatory effects, its influence on gut microbiota, and its potential in preventing organ damage in non-communicable diseases. It described rhodiola as an adaptogen that can provide personalized health strategies, which is rather a grand claim for a plant. The evidence base for rhodiola, taken alone, is rather more substantial than the evidence base for rhodiola taken with six other things in a proprietary blend.

Similarly, a review of Ocimum sanctum, known as holy basil or tulsi, cataloged its antibacterial, anti-diabetic, anti-carcinogenic, radioprotective, immunomodulatory, anti-inflammatory, cardioprotective and antidepressant characteristics. Eugenol, the active ingredient, has diverse therapeutic applications. The plant is known as an adaptogen. It was studied, extensively, on its own.

If one wishes to know which adaptogenic herbs should i take, the literature offers a clear answer for individual herbs and a rather less clear answer for combinations. The bottle lists five or seven or nine. The researchers tested one. It is rather like asking what the choir sounds like and being told repeatedly, in great detail, about the tenor.

One imagines the baritone has views.

What the Research Does Not Establish

The studies discussed here do not establish that combining adaptogenic herb combinations produces better outcomes than taking the herbs separately. They do not establish that synergy occurs. They do not measure interactions between compounds, beneficial or otherwise, in human subjects. They observe that people combine supplements, they express concern about it, and then they go back to testing individual herbs in isolation, which is apparently easier.

This is not a small omission.

If a product lists seven ingredients and promises that they work better together, one might reasonably expect at least one trial in which researchers gave humans the combination, measured something, and compared it to giving humans the individual ingredients separately. That trial does not appear in the available literature. What does appear is a succession of careful studies, each testing one herb at a time, in mice or in humans, under controlled conditions, and finding modest effects that are statistically significant and rather unspectacular in size.

Which is fine. Modest effects are useful.

But they are the effects of the individual herbs, not the combination.

The Bottle Versus the Evidence

The adaptogen combination formula benefits claimed on the label rest on studies that tested each ingredient in isolation. The promise of synergy rests on nothing measurable. It is not that synergy is impossible. It is that no one has demonstrated it in a trial, published the result, and made it available for citation by people who write about supplements for a living and would very much like to report something more interesting than 'they did not test the thing they are selling'.

The ashwagandha worked in trials. The rhodiola worked in trials. The holy basil worked in trials. Each of them, alone, in studies that took months to complete and involved actual humans or, in some cases, rather stressed mice.

Whether they work better together is a fine question. It remains a question.

One might purchase the combination anyway, on the theory that it cannot hurt, provided one is not taking anything that might interact badly with seven herbs at once, which the Saudi study suggested is a common situation and a reasonable concern. One might also purchase the individual herbs, take them at different times of day, and achieve more or less the same intake without paying for the claimed synergy that no trial has measured.

I leave the choice to the reader, who is presumably more interested in what actually happened in studies than in what a label implies might happen if one squints at the ingredient list and imagines a committee meeting.

The committee, one gathers, has not actually met.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Public knowledge, safety perceptions, and use patterns of ashwagandha (<i>Withania somnifera</i>) among Saudi adults: a mixed-methods study, Frontiers in pharmacology (2026).
2. Rhodiola rosea L. roots powder strongly reduces anxiety and corticosterone level induced by chronic stress in a murine model, Journal of pharmaceutical health care and sciences (2026).
3. Modulation of Various Pharmacological Pathways by Asparagus Saponins: Special Emphasis on Shatavarin-IV, Chemistry & biodiversity (2026).
4. Adaptogens in Long-Lasting Brain Fatigue: An Insight from Systems Biology and Network Pharmacology, Pharmaceuticals (Basel, Switzerland) (2025).
5. Harnessing the Antibacterial, Anti-Diabetic and Anti-Carcinogenic Properties of Ocimum sanctum Linn (Tulsi), Plants (Basel, Switzerland) (2024).
6. <i>Rhodiola rosea</i>: a review in the context of PPPM approach, The EPMA journal (2024).